| Revolution Medicines, Inc. |
Director |
Common Stock |
2.34M |
$93.1M |
$39.80 |
Jun 26, 2025 |
Direct |
| Magenta Therapeutics, Inc. |
Director |
Common Stock |
4.1K |
$49.2K |
$12.00 |
Aug 26, 2021 |
Direct |
| Tango Therapeutics, Inc. |
Director |
Common Stock |
17.5K |
$20K |
$1.14 |
Jun 5, 2025 |
Direct |
| Blueprint Medicines Corp |
Director |
Common Stock |
0 |
$0 |
$101.84 |
Jul 17, 2025 |
Direct |
| Relay Therapeutics, Inc. |
Director |
Stock Option (Right to Buy) |
137K |
|
|
Jun 6, 2025 |
Direct |
| Tango Therapeutics, Inc. |
Director |
Stock Option (Right to Buy) |
37.5K |
|
|
Jun 5, 2025 |
Direct |
| OPKO HEALTH, INC. |
Director |
Stock Option (Right to Buy) |
30K |
|
|
Jun 22, 2023 |
Direct |
| Magenta Therapeutics, Inc. |
Director |
Stock Option (Right to Buy) |
18.2K |
|
|
Jun 1, 2021 |
Direct |
| Revolution Medicines, Inc. |
Director |
Stock Option (Right to Buy) |
11.6K |
|
|
Jun 26, 2025 |
Direct |
| Blueprint Medicines Corp |
Director |
Stock Option (Right to Buy) |
0 |
|
|
Jul 17, 2025 |
Direct |
| EQRx, Inc. |
Executive Chairman, Director |
Common Stock |
0 |
|
$2.21 |
Nov 9, 2023 |
Direct |
| EQRx, Inc. |
Executive Chairman, Director |
Earn-out Shares |
0 |
|
|
Nov 9, 2023 |
Direct |
| EQRx, Inc. |
Executive Chairman, Director |
Stock Option (Right to Buy) |
0 |
|
|
Nov 9, 2023 |
Direct |